|
CL2025003637A1
(es)
|
|
Anticuerpos anti-tgf-beta 1 latente y métodos de uso.
|
|
BR102022025291A2
(https=)
|
|
|
|
BR102023008688A2
(https=)
|
|
|
|
BR102023007252A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR102023000289A2
(https=)
|
|
|
|
BR102022026909A2
(https=)
|
|
|
|
CN307045078S
(https=)
|
|
|
|
BY13167U
(https=)
|
|
|
|
CN307045783S
(https=)
|
|
|
|
CN307045726S
(https=)
|
|
|
|
BY13159U
(https=)
|
|
|
|
CN307044713S
(https=)
|
|
|
|
CN307047256S
(https=)
|
|
|
|
CN307044322S
(https=)
|
|
|
|
CN307044259S
(https=)
|
|
|
|
CN307047722S
(https=)
|
|
|
|
CN307047838S
(https=)
|
|
|
|
BY23966C1
(https=)
|
|
|
|
BY23965C1
(https=)
|
|
|
|
BY23963C1
(https=)
|
|
|
|
BY13176U
(https=)
|
|
|
|
BY13175U
(https=)
|
|
|
|
BY13174U
(https=)
|
|
|